Business Description
Heart Test Laboratories Inc
NAICS : 423450
SIC : 5047
ISIN : US42254E1047
Description
Heart Test Laboratories Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.61 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.17 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -10.58 | |||||
Beneish M-Score | -222.68 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -45 | |||||
3-Year EBITDA Growth Rate | 15.2 | |||||
3-Year EPS without NRI Growth Rate | 17.3 | |||||
3-Year FCF Growth Rate | 17 | |||||
Future 3-5Y Total Revenue Growth Rate | 784.98 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.92 | |||||
9-Day RSI | 46.47 | |||||
14-Day RSI | 43.21 | |||||
6-1 Month Momentum % | -68.18 | |||||
12-1 Month Momentum % | -94.18 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.2 | |||||
Quick Ratio | 3.84 | |||||
Cash Ratio | 3.32 | |||||
Days Inventory | 34685.43 | |||||
Days Sales Outstanding | 182.5 | |||||
Days Payable | 31671.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -103.7 | |||||
Shareholder Yield % | -344.82 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 63.16 | |||||
Operating Margin % | -33189.47 | |||||
Net Margin % | -34763.16 | |||||
FCF Margin % | -32605.26 | |||||
ROE % | -235.69 | |||||
ROA % | -115.65 | |||||
ROIC % | -303.85 | |||||
ROC (Joel Greenblatt) % | -812.66 | |||||
ROCE % | -175.23 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 53.08 | |||||
PB Ratio | 0.32 | |||||
Price-to-Tangible-Book | 0.44 | |||||
EV-to-EBIT | 0.29 | |||||
EV-to-EBITDA | 0.3 | |||||
EV-to-Forward-EBITDA | -1.08 | |||||
EV-to-Revenue | -95.68 | |||||
EV-to-Forward-Revenue | 24.21 | |||||
EV-to-FCF | 0.29 | |||||
Price-to-Net-Current-Asset-Value | 0.49 | |||||
Price-to-Net-Cash | 0.7 | |||||
Earnings Yield (Greenblatt) % | 344.83 | |||||
FCF Yield % | -209.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HSCS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Heart Test Laboratories Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.019 | ||
EPS (TTM) ($) | -34.729 | ||
Beta | 0 | ||
Volatility % | 49.79 | ||
14-Day RSI | 43.21 | ||
14-Day ATR ($) | 0.357807 | ||
20-Day SMA ($) | 3.530665 | ||
12-1 Month Momentum % | -94.18 | ||
52-Week Range ($) | 3.0301 - 85.18 | ||
Shares Outstanding (Mil) | 0.86 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Heart Test Laboratories Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Heart Test Laboratories Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Heart Test Laboratories Inc Frequently Asked Questions
What is Heart Test Laboratories Inc(HSCS)'s stock price today?
The current price of HSCS is $3.72. The 52 week high of HSCS is $85.18 and 52 week low is $3.03.
When is next earnings date of Heart Test Laboratories Inc(HSCS)?
The next earnings date of Heart Test Laboratories Inc(HSCS) is .
Does Heart Test Laboratories Inc(HSCS) pay dividends? If so, how much?
Heart Test Laboratories Inc(HSCS) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |